*

Hitt og þetta 5. september 2006

Zealand Pharma A/S raises EUR29m in rights issue

Nordic Business Report-September 5, 2006-Zealand Pharma A/S raises EUR29m in rights issue
(C)1994-2006 M2 COMMUNICATIONS LTD http://www.m2.com

The Danish biopharmaceutical company Zealand Pharma A/S said on Tuesday (5 September) that it has raised EUR29m in a rights issue.

The capital injection from existing shareholders brings Zealand Pharma's cash position to nearly EUR47m.

"The capital increase provides the necessary funding of Zealand Pharma's R&D efforts for the next 2-3 years which is a pivotal phase for the company," said Eva Steiness, CEO of Zealand Pharma.

"We are about to move one of our most advanced projects into the final phase of the clinical development cycle and at the same time we expect to initiate clinical development of several compounds from our drug discovery process. I am confident that our research work in the coming years will lead to new therapeutic options for heart and cancer patients," Steiness said.

One euro (EUR) is worth approximately 0.67 British pounds (GBP).

((Comments on this story may be sent to tww.feedback@m2.com))

25 ára afmælistilboð VB – 50% afsláttur af áskrift

Afmælistilboð VB

Viðskiptablaðið er 25 ára og af því tilefni býðst nýjum áskrifendum að kaupa áskrift á 50% afslætti.
Afmælisverðið er aðeins 2.500 krónur.

Tilboðið er fyrir nýja áskrifendur. Núverandi áskrifendur geta bætt við sig áskrift á þessu verði. Gildir í 4 mánuði. Áskrifendur fá Viðskiptablaðið, Frjálsa verslun og Fiskifréttir sent ásamt vefaðgangi að vb.is og fiskifrettir.is